Cargando…

Organoid technology for personalized pancreatic cancer therapy

BACKGROUND: Pancreatic ductal adenocarcinoma has the lowest survival rate among all major cancers and is the third leading cause of cancer-related mortality. The stagnant survival statistics and dismal response rates to current therapeutics highlight the need for more efficient preclinical models. P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bengtsson, Axel, Andersson, Roland, Rahm, Jonas, Ganganna, Karthik, Andersson, Bodil, Ansari, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985124/ https://www.ncbi.nlm.nih.gov/pubmed/33492660 http://dx.doi.org/10.1007/s13402-021-00585-1

Ejemplares similares

The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
por: Bengtsson, Axel, et al.
Publicado: (2020)

Immune checkpoint therapy for pancreatic cancer
por: Johansson, Henrik, et al.
Publicado: (2016)

Safety of pancreatic resection in the elderly: a retrospective analysis of 556 patients
por: Ansari, Daniel, et al.
Publicado: (2016)

Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015)

Proteomic and genomic profiling of pancreatic cancer
por: Ansari, Daniel, et al.
Publicado: (2019)

SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer
por: Vaz, Juan, et al.
Publicado: (2015)

Pancreatic cancer screening in high-risk individuals with genetic susceptibility
por: Andersson, Roland, et al.
Publicado: (2023)

Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment
por: Ansari, Daniel, et al.
Publicado: (2018)

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
por: Bauden, Monika, et al.
Publicado: (2017)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
por: Ansari, Daniel, et al.
Publicado: (2014)

Early-onset pancreatic cancer: a population-based study using the SEER registry
por: Ansari, Daniel, et al.
Publicado: (2019)

CODUSA - Customize Optimal Donor Using Simulated Annealing In Heart Transplantation
por: Ansari, Daniel, et al.
Publicado: (2013)

Application of Cancer Organoid Model for Drug Screening and Personalized Therapy
por: Kondo, Jumpei, et al.
Publicado: (2019)

Development of glioblastoma organoids and their applications in personalized therapy
por: Xu, Can, et al.
Publicado: (2023)

Surgical exploration without resection in pancreatic and periampullary tumors: Report from a national database
por: Sahlström, Emil, et al.
Publicado: (2020)

Organoid technology and applications in cancer research
por: Xu, Hanxiao, et al.
Publicado: (2018)

Cancer research using organoid technology
por: Kretzschmar, Kai
Publicado: (2020)

Oncolytic virotherapy meets the human organoid technology for pancreatic cancers
por: Fiorini, Elena, et al.
Publicado: (2020)

Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma
por: Byrling, Johannes, et al.
Publicado: (2017)

Cholecystectomy After Previous Bariatric Surgery with Special Focus on Pregnant Patients—Results from Two Large Nationwide Registries
por: Hedström, Jonas, et al.
Publicado: (2020)

Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine
por: Xu, Hanxiao, et al.
Publicado: (2018)

Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis
por: Ansari, David, et al.
Publicado: (2015)

Tumor organoids for cancer research and personalized medicine
por: Yang, Hui, et al.
Publicado: (2022)

Patient-derived organoids for therapy personalization in inflammatory bowel diseases
por: Lucafò, Marianna, et al.
Publicado: (2022)

Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
por: Kriz, D., et al.
Publicado: (2020)

Organoid technology for tissue engineering
por: He, Juan, et al.
Publicado: (2020)

Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis
por: Torén, William, et al.
Publicado: (2018)

Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer
por: Moreira, Leticia, et al.
Publicado: (2017)

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
por: Sereti, Evangelia, et al.
Publicado: (2023)

Application of Patient-Derived Cancer Organoids to Personalized Medicine
por: Shiihara, Masahiro, et al.
Publicado: (2022)

Lung Cancer Organoids: The Rough Path to Personalized Medicine
por: Rossi, Rachele, et al.
Publicado: (2022)

Preoperative Risk Score for Early Mortality After Up-Front Pancreatic Cancer Surgery: A Nationwide Cohort Study
por: Bereza-Carlson, Paulina, et al.
Publicado: (2022)

Making human pancreatic islet organoids: Progresses on the cell origins, biomaterials and three-dimensional technologies
por: Jiang, Lai, et al.
Publicado: (2022)

Pancreatic Progenitors and Organoids as a Prerequisite to Model Pancreatic Diseases and Cancer
por: Hohwieler, Meike, et al.
Publicado: (2019)

Surgery A survey of patients' perceptions and experiences of intervention for gallstone disease during pregnancy
por: Hedström, Jonas, et al.
Publicado: (2022)

Emerging liver organoid platforms and technologies
por: Lam, Do Thuy Uyen Ha, et al.
Publicado: (2021)

Organoid technology in female reproductive biomedicine
por: Heidari-Khoei, Heidar, et al.
Publicado: (2020)

Advancement of Organoid Technology in Regenerative Medicine
por: Arjmand, Babak, et al.
Publicado: (2022)

Applications of organoid technology to brain tumors
por: Wen, Jie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f3vcqjn64qhr2eieopru9ad59l